# Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer

> **NCT01218594** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 50 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Endostatin

## Key facts

- **NCT ID:** NCT01218594
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2013-12
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-10-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218594, "Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01218594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*